![Allan Reine](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Allan Reine
Chief Executive Officer at
PRIME MEDICINE, INC.
Net worth: 448 750 $ as of 2026-08-30
Profile
Allan Jacob Reine is Chief Executive Officer & Director at Prime Medicine, Inc. since 2026 and Independent Non-Executive Director at ONK Therapeutics Ltd. since 2022.
Former roles include Chief Financial & Accounting Officer, Treasurer at Pieris Pharmaceuticals, Inc. from 2017 to 2019; Chief Financial Officer at Foghorn Therapeutics, Inc. from 2019 to 2024; Portfolio Manager at Citigroup Alternative Investments LLC from 2010 to 2012; Principal at Trivium Capital Management LLC in 2008; Portfolio Manager at CR Intrinsic Investors LLC in 2007; Portfolio Manager at S.A.C.
Capital Advisors LP in 2007; Research Analyst at Alexandra Investment Management LLC from 2003 to 2005; Analyst at CIBC World Markets Corp.
in 2003; and roles at Lombard Odier Asset Management (USA) Corp.
and Citi Principal Strategies.
Education includes a doctorate from the University of Toronto in 2001 and an undergraduate degree from the University of Western Ontario in 1997.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PRIME MEDICINE, INC. 0.07% | 2026-03-30 | 125,000 ( 0.07% ) | 448 750 $ | 2026-08-30 |
Allan Reine active positions
| Companies | Position | Start |
|---|---|---|
| PRIME MEDICINE, INC. | Chief Executive Officer | 2025-05-18 |
ONK Therapeutics Ltd.
 ONK Therapeutics Ltd. BiotechnologyHealth Technology Develops bio cells for anti cancer therapies | Director/Board Member | 2022-03-22 |
Former positions of Allan Reine
| Companies | Position | End |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Director of Finance/CFO | 2024-01-15 |
| PIERIS PHARMACEUTICALS | Director of Finance/CFO | 2019-09-12 |
Citigroup Alternative Investments LLC
 Citigroup Alternative Investments LLC Investment ManagersFinance CAI’s investment team generally employs fundamental research, specific industry knowledge, proprietary relationships, and partnerships with management teams to identify attractive investment opportunities, often targeting industries that are undergoing change or are otherwise out-of-favor for their Private Equity Investment Fund. For their real estate funds, the firm selects underlying funds based on their performance track record, organizational ability to execute the investment strategy, and financial capacity to meet obligations, among other factors. | Portfolio Manager-Equities | 2012-01-31 |
S.A.C. Capital Advisors LP
 S.A.C. Capital Advisors LP Investment ManagersFinance S.A.C. Capital Advisors seeks to invest in the stocks of companies with short-term growth catalysts. The firm employs quantitative techniques and merger arbitrage strategies. | Analyst-Equity | 2007-12-30 |
Trivium Capital Management LLC
 Trivium Capital Management LLC Investment ManagersFinance Trivium is a global long/short opportunistic small-cap investor. They focus on several sectors including, but not limited to, technology, technology services, retail and commercial services. Trivium maintains a high turnover | Head-Equity Investments | 2008-07-31 |
Training of Allan Reine
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
94
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
CIBC World Markets Corp. (Old)
 CIBC World Markets Corp. (Old) Financial ConglomeratesFinance Provides financial services | Finance |
S.A.C. Capital Advisors LP
S.A.C. Capital Advisors LP Investment ManagersFinance S.A.C. Capital Advisors seeks to invest in the stocks of companies with short-term growth catalysts. The firm employs quantitative techniques and merger arbitrage strategies. | Finance |
Alexandra Investment Management LLC
 Alexandra Investment Management LLC Investment ManagersFinance Alexandra manages the Alexandra Global Investment Fund I, Ltd. and the Alexandra Global Investment Fund LP. The firm is a global multi-strategy investor. They specialize in event-driven relative value strategies. Alexandra invests in a wide variety of asset classes, markets and strategies including: event driven, relative value, special situations, equity long/short, convertible bonds, high yield, distressed debt, capital structure arbitrage strategies and PIPEs. Alexandra uses a combination of fundamental and quantitative approach for their credit and equity research. The firm maintains a high turnover rate | Finance |
Citigroup Alternative Investments LLC
Citigroup Alternative Investments LLC Investment ManagersFinance CAI’s investment team generally employs fundamental research, specific industry knowledge, proprietary relationships, and partnerships with management teams to identify attractive investment opportunities, often targeting industries that are undergoing change or are otherwise out-of-favor for their Private Equity Investment Fund. For their real estate funds, the firm selects underlying funds based on their performance track record, organizational ability to execute the investment strategy, and financial capacity to meet obligations, among other factors. | Finance |
Trivium Capital Management LLC
Trivium Capital Management LLC Investment ManagersFinance Trivium is a global long/short opportunistic small-cap investor. They focus on several sectors including, but not limited to, technology, technology services, retail and commercial services. Trivium maintains a high turnover | Finance |
Lombard Odier Asset Management (USA) Corp.
 Lombard Odier Asset Management (USA) Corp. Investment ManagersFinance LOAM offers a variety of investment strategies when managing their funds. The strategies generally follow a risk-based methodology where risk is allocated between the various premia. By combining them using a proprietary risk-based methodology, the strategies target smoother returns in different market conditions, which are less exposed to drawdowns and to specific risks linked to individual strategies. | Finance |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CR Intrinsic Investors LLC
 CR Intrinsic Investors LLC Investment ManagersFinance CR Intrinsic Investors employs a multi-strategy approach to make long/short primarily in the stocks of US companies across all market-caps. | Finance |
Citi Principal Strategies
 Citi Principal Strategies Financial ConglomeratesFinance Proprietary trading entity of Citigroup | Finance |
Pieris Pharmaceuticals, Inc.
 Pieris Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets an anticalin-brand protein technology | Health Technology |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
ONK Therapeutics Ltd.
ONK Therapeutics Ltd. BiotechnologyHealth Technology Develops bio cells for anti cancer therapies | Health Technology |
Prime Medicine, Inc.
 Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology | Health Technology |
- Stock Market
- Insiders
- Allan Reine
